XML 35 R25.htm IDEA: XBRL DOCUMENT
v3.22.1

STOCKHOLDERS' EQUITY (Tables) | 9 Months Ended
--- | ---
Mar. 31, 2022
Equity [Abstract] |
Schedule of Stockholders Equity | Changes in the components of Stockholders’ equity were as follows for the periods indicated:
| Three Months Ended March 31
(Dollars in millions except per share data; shares in thousands) | Common Stock |  | Additional Paid-in Capital |  | Retained Earnings |  | Treasury Stock |  | Accumulated Other Comprehensive Net (Loss) Income |  | Non-controlling interests |  | Total Stockholders’ Equity
Amount |  | Shares |  |  |  | Amount |  | Shares |  |  |
Balance as of December 31, 2020 | $ | 131 |  |  | 130,741 |  |  | $ | 1,176 |  |  | $ | 1,302 |  |  | $ | (850) |  |  | (5,017) |  |  | $ | (575) |  |  | $ | 196 |  |  | $ | 1,380 |
Net earnings (losses) | — |  |  | — |  |  | — |  |  | (61) |  |  | — |  |  | — |  |  | — |  |  | 2 |  |  | (59) |
Other comprehensive (loss) income | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 22 |  |  | — |  |  | 22 |
Dividends to Clorox stockholders ($1.11 per share declared) | — |  |  | — |  |  | — |  |  | (139) |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (139) |
Dividends to non-controlling interests | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (3) |  |  | (3) |
Stock-based compensation | — |  |  | — |  |  | 17 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 17 |
Other employee stock plan activities | — |  |  | — |  |  | (3) |  |  | (16) |  |  | 44 |  |  | 283 |  |  | — |  |  | — |  |  | 25 |
Treasury stock purchased | — |  |  | — |  |  | — |  |  | — |  |  | (305) |  |  | (1,648) |  |  | — |  |  | — |  |  | (305) |
Balance as of March 31, 2021 | $ | 131 |  |  | 130,741 |  |  | $ | 1,190 |  |  | $ | 1,086 |  |  | $ | (1,111) |  |  | (6,382) |  |  | $ | (553) |  |  | $ | 195 |  |  | $ | 938 |
Balance as of December 31, 2021 | $ | 131 |  |  | 130,741 |  |  | $ | 1,180 |  |  | $ | 949 |  |  | $ | (1,373) |  |  | (7,777) |  |  | $ | (574) |  |  | $ | 178 |  |  | $ | 491 |
Net earnings | — |  |  | — |  |  | — |  |  | 150 |  |  | — |  |  | — |  |  | — |  |  | 2 |  |  | 152 |
Other comprehensive (loss) income | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 55 |  |  | — |  |  | 55 |
Dividends to Clorox stockholders ($1.16 per share declared) | — |  |  | — |  |  | — |  |  | (143) |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (143) |
Dividends to non-controlling interests | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (4) |  |  | (4) |
Stock-based compensation | — |  |  | — |  |  | 19 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 19 |
Other employee stock plan activities | — |  |  | — |  |  | (4) |  |  | (5) |  |  | 15 |  |  | 107 |  |  | — |  |  | — |  |  | 6 |
Balance as of March 31, 2022 | $ | 131 |  |  | 130,741 |  |  | $ | 1,195 |  |  | $ | 951 |  |  | $ | (1,358) |  |  | (7,670) |  |  | $ | (519) |  |  | $ | 176 |  |  | $ | 576 |
| Nine Months Ended March 31
(Dollars in millions except per share data; shares in thousands) | Common Stock |  | Additional Paid-in Capital |  | Retained Earnings |  | Treasury Stock |  | Accumulated Other Comprehensive Net (Loss) Income |  | Non-controlling interests |  | Total Stockholders’ Equity
Amount |  | Shares |  |  |  | Amount |  | Shares |  |  |
Balance as of June 30, 2020 | $ | 159 |  |  | 158,741 |  |  | $ | 1,137 |  |  | $ | 3,567 |  |  | $ | (3,315) |  |  | (32,543) |  |  | $ | (640) |  |  | $ | — |  |  | $ | 908 |
Net earnings | — |  |  | — |  |  | — |  |  | 613 |  |  | — |  |  | — |  |  | — |  |  | 6 |  |  | 619 |
Other comprehensive (loss) income | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 87 |  |  | — |  |  | 87 |
Dividends to Clorox stockholders ($3.33 per share declared) | — |  |  | — |  |  | — |  |  | (421) |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (421) |
Dividends to noncontrolling interests | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (9) |  |  | (9) |
Business combinations including purchase accounting adjustments | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 198 |  |  | 198 |
Stock-based compensation | — |  |  | — |  |  | 52 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 52 |
Other employee stock plan activities | — |  |  | — |  |  | 1 |  |  | (33) |  |  | 141 |  |  | 1,233 |  |  | — |  |  | — |  |  | 109 |
Treasury stock purchased | — |  |  | — |  |  | — |  |  | — |  |  | (605) |  |  | (3,072) |  |  | — |  |  | — |  |  | (605) |
Treasury stock retirement (1) | (28) |  |  | (28,000) |  |  | — |  |  | (2,640) |  |  | 2,668 |  |  | 28,000 |  | $ | — |  |  | — |  |  | — |
Balance as of March 31, 2021 | $ | 131 |  |  | 130,741 |  |  | $ | 1,190 |  |  | $ | 1,086 |  |  | $ | (1,111) |  |  | (6,382) |  |  | $ | (553) |  |  | $ | 195 |  |  | $ | 938 |
Balance as of June 30, 2021 | $ | 131 |  |  | 130,741 |  |  | $ | 1,186 |  |  | $ | 1,036 |  |  | $ | (1,396) |  |  | (7,961) |  |  | $ | (546) |  |  | $ | 181 |  |  | $ | 592 |
Net earnings | — |  |  | — |  |  | — |  |  | 361 |  |  | — |  |  | — |  |  | — |  |  | 6 |  |  | 367 |
Other comprehensive (loss) income | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 27 |  |  | — |  |  | 27 |
Dividends to Clorox stockholders ($3.48 per share declared) | — |  |  | — |  |  | — |  |  | (430) |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (430) |
Dividends to noncontrolling interests | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (11) |  |  | (11) |
Stock-based compensation | — |  |  | — |  |  | 44 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 44 |
Other employee stock plan activities | — |  |  | — |  |  | (35) |  |  | (16) |  |  | 63 |  |  | 443 |  |  | — |  |  | — |  |  | 12 |
Treasury stock purchased | — |  |  | — |  |  | — |  |  | — |  |  | (25) |  |  | (152) |  |  | — |  |  | — |  |  | (25) |
Balance as of March 31, 2022 | $ | 131 |  |  | 130,741 |  |  | $ | 1,195 |  |  | $ | 951 |  |  | $ | (1,358) |  |  | (7,670) |  |  | $ | (519) |  |  | $ | 176 |  |  | $ | 576 |
(1) On November 18, 2020 the Company retired 28 million shares of its treasury stock. These shares are now authorized but unissued. There was no effect on the Company’s overall equity position as a result of the retirement.
Schedule of Changes in Accumulated Other Comprehensive Net (Losses) Income | Changes in Accumulated other comprehensive net (loss) income attributable to Clorox by component were as follows for the periods indicated:
| Three Months Ended March 31
| Foreign currency translation adjustments |  | Net unrealized gains (losses) on derivatives |  | Pension and postretirement benefit adjustments |  | Accumulated other comprehensive net (loss) income
Balance as of December 31, 2020 | $ | (403) |  |  | $ | (3) |  |  | $ | (169) |  |  | $ | (575) |
Other comprehensive (loss) income before reclassifications | (6) |  |  | 33 |  |  | — |  |  | 27 |
Amounts reclassified from Accumulated other comprehensive net (loss) income | — |  |  | 2 |  |  | 3 |  |  | 5 |
Income tax benefit (expense) | (1) |  |  | (8) |  |  | (1) |  |  | (10) |
Net current period other comprehensive (loss) income | (7) |  |  | 27 |  |  | 2 |  |  | 22 |
Balance as of March 31, 2021 | $ | (410) |  |  | $ | 24 |  |  | $ | (167) |  |  | $ | (553) |
Balance as of December 31, 2021 | $ | (431) |  |  | $ | 18 |  |  | $ | (161) |  |  | $ | (574) |
Other comprehensive (loss) income before reclassifications | 19 |  |  | 48 |  |  | — |  |  | 67 |
Amounts reclassified from Accumulated other comprehensive net (loss) income | — |  |  | (3) |  |  | 2 |  |  | (1) |
Income tax benefit (expense), and other | — |  |  | (11) |  |  | — |  |  | (11) |
Net current period other comprehensive (loss) income | 19 |  |  | 34 |  |  | 2 |  |  | 55 |
Balance as of March 31, 2022 | $ | (412) |  |  | $ | 52 |  |  | $ | (159) |  |  | $ | (519) |
| Nine Months Ended March 31
| Foreign currency translation adjustments |  | Net unrealized gains (losses) on derivatives |  | Pension and postretirement benefit adjustments |  | Accumulated other comprehensive net (loss) income
Balance as of June 30, 2020 | $ | (450) |  |  | $ | (18) |  |  | $ | (172) |  |  | $ | (640) |
Other comprehensive (loss) income before reclassifications | 38 |  |  | 47 |  |  | — |  |  | 85 |
Amounts reclassified from Accumulated other comprehensive net (loss) income | — |  |  | 7 |  |  | 7 |  |  | 14 |
Income tax benefit (expense) | 2 |  |  | (12) |  |  | (2) |  |  | (12) |
Net current period other comprehensive (loss) income | 40 |  |  | 42 |  |  | 5 |  |  | 87 |
Balance as of March 31, 2021 | $ | (410) |  |  | $ | 24 |  |  | $ | (167) |  |  | $ | (553) |
Balance as of June 30, 2021 | $ | (403) |  |  | $ | 21 |  |  | $ | (164) |  |  | $ | (546) |
Other comprehensive (loss) income before reclassifications | (9) |  |  | 51 |  |  | — |  |  | 42 |
Amounts reclassified from Accumulated other comprehensive net (loss) income | — |  |  | (10) |  |  | 6 |  |  | (4) |
Income tax benefit (expense), and other | — |  |  | (10) |  |  | (1) |  |  | (11) |
Net current period other comprehensive (loss) income | (9) |  |  | 31 |  |  | 5 |  |  | 27 |
Balance as of March 31, 2022 | $ | (412) |  |  | $ | 52 |  |  | $ | (159) |  |  | $ | (519) |

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the components of accumulated other comprehensive income (loss). + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 830 -SubTopic 30 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 14A -URI http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 830 -SubTopic 30 -Section 45 -Paragraph 20 -URI http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900 + Details
Name: | us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of changes in the separate accounts comprising stockholders' equity (in addition to retained earnings) and of the changes in the number of shares of equity securities during at least the most recent annual fiscal period and any subsequent interim period presented is required to make the financial statements sufficiently informative if both financial position and results of operations are presented. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644 + Details
Name: | us-gaap_ScheduleOfStockholdersEquityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration